087010.KQ
Peptron, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 146,600.00
−6.92%Year over year
Reported trailing growth
- Revenue
- +15.9%
- EBITDA
- —
- EBIT
- -46.2%
- EPS
- -14.1%
- Free cash flow
- -77.4%
- Operating cash flow
- -36.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.0%
- EBITDA
- -0.5%
- EBIT
- -28.6%
- Net income
- +37.3%
- EPS
- +44.1%
- Free cash flow
- -54.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026